releasing factor receptor subtype 1 (CRF 1 ) expressed on MCs. Objective: In this study we investigated the role of corticotropin-releasing factor receptor subtype 2 (CRF 2 ) as a modulator of stress-induced MC degranulation and associated disease pathophysiology. Methods: In vitro MC degranulation assays were performed with bone marrow-derived mast cells (BMMCs) derived from wildtype (WT) and CRF 2 -deficient (CRF 2 2/2 ) mice and RBL-2H3 MCs transfected with CRF 2 -overexpressing plasmid or CRF 2 small interfering RNA. In vivo MC responses and associated pathophysiology in IgE-mediated passive systemic anaphylaxis and acute psychological restraint stress were measured in WT, CRF 2 2/2 , and MC-deficient Kit W-sh/W-sh knock-in mice.
Results: Compared with WT mice, CRF 2 2/2 mice exhibited greater serum histamine levels and exacerbated IgE-mediated anaphylaxis and colonic permeability. In addition, CRF 2 Psychological stress has a major influence on immune function and is a risk factor in many immune-related disorders. Although numerous studies have investigated the influence of different stress paradigms on immune function and disease susceptibility, the underlying signaling pathways remain to be elucidated. Mast cells (MCs) have become recognized as important early immune effector cells in the stress response and stress-related pathophysiology. MCs are strategically positioned close to neurovascular units and host-environment interfaces (eg, mucosal epithelial barriers) and express a repertoire of receptors to sense and respond rapidly to a continuous array of stress signals from neuroendocrine, immunologic, and environmental stimuli. When activated, MCs release an array of preformed granule mediators, including histamine proteases, and select cytokines through degranulation, which trigger rapid and robust physiologic effects, such as changes in blood flow, increased endothelial and epithelial permeability, hypersecretion, and immune cell activation and recruitment. [1] [2] [3] [4] [5] [6] Stress-induced MC degranulation and the associated tissue pathophysiology likely represent a critical host defense strategy to mobilize critical resources for the fight or flight response and to enhance immune function; however, if uncontrolled MC activation can be detrimental and has been linked to the onset and severity of diseases, including allergy, asthma, and irritable bowel syndrome (IBS). [7] [8] [9] [10] [11] The corticotropin-releasing factor (CRF) system is a major stress regulatory system in the body 12 and is composed of a family of peptide-related CRFs and the related family of urocortins (I-III), which mediate their actions through the G proteincoupled receptors (GPCRs) CRF 1 and CRF 2 . The role of the CRF system has been extensively studied in the central nervous system with regard to HPA axis regulation and neurobehavioral paradigms. 12, 13 More recently, the CRF system has been shown to be highly active in peripheral immunologic and infectious challenge conditions, [14] [15] [16] [17] suggesting an important role in immune function. Comparatively little is known about the role of the CRF system in regulating the function of specific immune cells, such as MCs. MCs express both CRF 1 and CRF 2 18-20 and can synthesize and release ligands CRF and urocortins. 21, 22 Pharmacologic stimulation of CRF receptors on human and rodent MCs in vitro was shown to induce canonical GPCR signaling pathways, such as cyclic AMP Ca 21 and phosphorylated extracellular signal-regulated kinase, and the selective release of de novo synthesized growth factors and cytokines, 18, 19, 23 whereas CRF receptor ligands did not induce degranulation. The in vivo role of MCexpressed CRF receptors has remained elusive; however, we recently demonstrated that CRF 1 expressed on MCs acts as a positive modulator of stress-induced MC degranulation and associated tissue pathophysiology in response to anaphylaxis and psychological stress. 22 In the present study we demonstrate that the complementary CRF receptor subtype CRF 2 is a negative modulator of MC degranulation and associated pathophysiologic responses to immunologic and psychological stressors, thus further supporting a critical homeostatic role for the MC-specific CRF system in MC activation and MC-associated diseases.
METHODS

Ethics statement
All protocols were approved by the North Carolina State University (protocol 09-047B) and Michigan State University's Institutional Animal Care and Use Committee (protocol 03/15-039-00). In the knockout mice the 3 exons which encode for the intracellular loop of the CRF 2 cytoplasmic region have been replaced with a neomycin resistance cassette, as described earlier. 24 Standard PCR was used to genotype WT and CRF 2 2/2 mice and bone marrow-derived mast cells (BMMCs) through both in house and commercial services (GeneTyper, New York, NY) by using protocols published at www.jax.org.
Abbreviations used
Passive systemic anaphylaxis
WT and CRF 2 2/2 female mice (8 weeks of age) were sensitized by means of intraperitoneal injection with 20 mg of IgE monoclonal anti-dinitrophenyl in 100 mL of PBS. The following day, mice were challenged with 1 mg of dinitrophenyl (DNP) in 100 mL of PBS (administered intraperitoneally). The mice were constantly observed, and rectal body temperature was recorded for 0, 15, 30, 60 and 120 minutes after DNP challenge (TH-5 Thermalert; Physitemp, Clifton, NJ). Mice were euthanized at 0 and 30 minutes after DNP injection for serum collection through cardiac puncture and stored at 2808C until serum histamine levels were quantified by using a commercial EIA kit (Oxford Biomedical Research, Rochester Hills, Mich).
For antalarmin experiments, passive systemic anaphylaxis (PSA) was performed as indicated above with the additional treatment group of antalarmin-treated CRF 2 2/2 mice. Antalarmin (15 mg/kg) was injected (intraperitoneally) in male mice 15 minutes before DNP challenge. Mice were euthanized 30 minutes after DNP injection, and plasma was collected by means of cardiac puncture for later histamine analysis.
Histamine measurements
Histamine concentrations were quantified in serum, plasma, and cell pellets and supernatants from stimulated MC cultures with a histamine EIA kit (Oxford Biomedical Research).
Quantification of tissue MC numbers
Small intestinal mesentery windows from WT and CRF 2 2/2 mice were whole mounted on glass slides, fixed with Carnoy fixative, and stained with toluidine blue (Sigma-Aldrich, St Louis, Mo), as described previously. 25 Hearts and ears from the same mice were fixed in 4% paraformaldehyde embedded in paraffin, and deparaffinized sections were stained with toluidine blue. Toluidine blue-stained MCs were counted in 5 nonoverlapping microscopic fields at a magnification of 3400. Each field contained tissue sections that filled the entire high-power field. Mesentery MCs were counted in at least 6 mesenteric widows per mouse (n 5 4 per genotype). Before performing tissue counts, each slide was coded so that counts were performed in a blinded manner. The average number of MCs per high-power field was then calculated for each tissue and within each genotype.
WBC differential count
Blood was collected by means of cardiac puncture from WT and CRF 2 2/2 female mice and placed into EDTA-treated tubes (Microvette, N€ umbrecht, Germany). Blood smears were performed, followed by a differential WBC count (number of basophils/100 WBCs).
Ussing chamber studies
Distal small intestine (ileum) was harvested from each mouse immediately after death and opened along the antimesenteric border. The intestinal mucosa was stripped from the seromuscular layer in oxygenated (95% O 2 and 5% 2 ) and circulated in water-jacketed reservoirs maintained at 378C.
The spontaneous potential difference (PD) was measured by using Ringeragar bridges connected to calomel electrodes, and the PD was short-circuited through Ag-AgCl electrodes by using a voltage clamp that corrected for fluid resistance. Tissues were maintained in the short-circuited state, except for brief intervals to record the open-circuit PD.
Transepithelial electrical resistance (TER; measured as V , cm 2 ) was calculated from the spontaneous PD and short-circuit current, as previously described. 26 After a 30-minute equilibration period on the Ussing chambers, TER was recorded at 15-minute intervals over a 1-hour period and then averaged to derive the basal TER values for a given animal. After a 30-minute equilibration period on Ussing chambers, FD4 (100 mg/mL; Sigma, St Louis, Mo) was added to the mucosal bathing reservoir of the Ussing chambers. After a 15-minute equilibration period, standards were taken from the serosal side of each chamber, and a 60-minute flux period was established by taking 0.5-mL samples from the mucosal compartment. The quantity of FD4 was established by measuring the fluorescence in mucosal reservoir fluid samples in a fluorescence plate reader at 540 nm. Data are presented as the rate of FD4 flux in nanograms of FD4 per minute per square centimeter.
BMMC and RBL-2H3 cell cultures
Bone marrow cells were derived from female WT and CRF 2 2/2 mice at approximately 4 to 6 weeks of age. Isolated bone marrow progenitor cells were cultured in RPMI 1640 media (with L-glutamine) supplemented with FBS (10%), sodium pyruvate (1 mmol/L), MEM nonessential amino acids (13), HEPES buffer (10 mmol/L), penicillin (100 U/mL) and streptomycin (100 mg/mL), and recombinant cytokines (stem cell factor, 5 ng/ mL; IL-3, 5 ng/mL]). After 4 weeks, cultures were composed mainly of MCs (93%), as determined by using toluidine blue staining and flow cytometric analysis (BD LSR II) by using fluorescently labeled c-kit (BioLegend, San Diego, Calif), high-affinity IgE receptor (FcεRI) antibodies (eBioscience, San Diego, Calif), and CRF 2 anti-rabbit. Media and supplements were purchased from Cellgro (Corning, Manassas, Va) and recombinant cytokines from R&D Systems (Minneapolis, Minn). The rat basophilic leukemia cell MC line (RBL-2H3) was grown in MEM medium with 10% FBS.
Confocal immunofluorescence staining
BMMCs and peritoneal MCs were obtained from 8-week-old female C57Bl/6 mice, as previously described. 25 Cells were pelleted, washed once with 13 PBS, cytospun onto slides, and fixed with 4% paraformaldehyde for 20 minutes at 48C. Slides were blocked at room temperature for 1 hour with blocking buffer (10% normal donkey serum and 0.3% Triton X-100) in 13 PBS, permeabilized (0.1% Triton X-100), and incubated with goat anti-CRF 1 (NB1-00175; Novus Biologicals, Centennial, Colo) and rabbit anti-CRF 2 (NBP100-56485, Novus Biologicals) in dilution buffer at a concentration of 1:100 diluted in 1% BSA in a humidified chamber overnight at 48C. Slides were washed 3 times for 5 minutes and then incubated with anti-rabbit-Cy3 and anti-goat-fluorescein isothiocyanate secondary antibodies in dilution buffer (1:300) for 1 hour at room temperature in the dark. Slides were washed 3 times for 5 minutes with 13 PBS, and ProLong Diamond Antifade Mountant with 49-6-diamidino-2-phenylindole dihydrochloride (P36971; Thermo Fisher, Waltham, Mass) was added before placement under cover slips. Confocal images were obtained with the Olympus FV 1000 confocal laser scanning microscope (Olympus America, Center Valley, Pa).
b-Hexosaminidase assay
RBL-2H3 cells or murine BMMCs (2 3 10
6 cells/mL) were sensitized overnight at 378C with 1 mg/mL anti-DNP IgE (Sigma-Aldrich) in complete RPMI medium with cytokines. The following day, cells were washed and resuspended in Tyrode buffer, and BMMCs were seeded in a 96-well plate (0.45 3 10 6 cells/well). Cells were equilibrated for an hour and stimulated with the indicated concentrations of DNP-albumin (Sigma-Aldrich) for 1 hour at 378C. For A23187 and C48/80 stimulation, unsensitized BMMCs were stimulated for 1 hour. b-Hexosaminidase (b-Hex) activity was measured by addition of p-nitrophenol-N-acetyl-a-D-glucosaminide in 0.1 mol/L sodium citrate (pH 4.5) for 1 hour at 378C. The reaction was terminated with 0.1 mol/L carbonate buffer (pH 10.0), and absorbance was recorded at 405 nm. The percentage of degranulation was calculated by dividing optical absorbance of the supernatant by the sum of optical absorbance of the supernatant and cell pellet (lysed with 0.1% Triton X-100) and multiplying by 100.
CRF 2 overexpression and knockdown in RBL-2H3 MCs
The Lenti-ORF clone of CRF 2 (CRHR2), transcript variant 1, and membrane bound green flourescent protein-tagged plasmid were obtained from OriGene (Rockville, Md; catalog no. RG222881). CRF 2 short hairpin RNA (shRNA) clones (MSH028936-LVRU6MH) were purchased from GeneCopoeia (Rockville, Md). DH5 a-competent cells were obtained from Invitrogen (Carlsbad, Calif; catalog no. 18265017), and the plasmids were transfected and plated on selective antibiotic resistance LB plates, according to the manufacturer's protocol. After overnight incubation at 378C, a single colony was picked for each clone and inoculated on 2.5 mL of LB medium containing antibiotics and kept for 8 hours at 378C at 200 rpm. A total of 600 mL of culture inoculum was transferred into 300 mL of LB broth on a sterile 1-L flask with antibiotics and kept at 200 rpm at 378C overnight. Plasmid was extracted, and the concentration was measured according to the manufacturer's protocol (catalog no. 12662; Qiagen, Hilden, Germany).
Human embryonic kidney cell 293Ta lentivirus cells were seeded at a concentration of 1.5 3 10 6 cells per well (6 well), and 2.5 mg of CRF 2 -overexpressed or CRF 2 shRNA, along with respective control empty green fluorescent protein (GFP) or scrambled shRNA plasmid control DNA, was transfected with the Lentiviral Packaging Kit (catalog no. TR30022; OriGene), according to the manufacturer's protocol. After overnight incubation at 378C with 5% CO 2 , transfection medium was replaced with normal 5% Dulbecco modified Eagle medium with Polybrene (1 mL of 4 mg/mL). Forty-eight hours after transfection, the supernatant was collected from the 6-well plate and filtered onto a Nalgene ultracentrifuge tube, and 5 mL of 20% sucrose was added to the bottom of the tube. After centrifugation at 25,000 rpm for 2 hours at 48C, the supernatant was discarded, and the lentivirus-overexpressing CRF 2 plasmid or CRF 2 shRNA pellet was resuspended with 150 mL of 4% lactose and kept on ice for 15 minutes and centrifuged at a high speed for 1 minute. Lentiviral aliquots were stored at 2808C until transfection.
Lentivirus titering was done, and RBL-2H3 cells at a concentration of 2.5 3 10 5 cells were plated on a 12-well plate and grown overnight. Lentivirusoverexpressing CRHR2 or CRF 2 shRNA plasmid at a multiplicity of infection of 40 and Polybrene at a final concentration of 8 mg/mL was added to each well, and plates were centrifuged at 300g for 60 minutes at 308C. The plate was incubated at 378C overnight, and the medium was replaced with 15% MEM. After 48 hours of transfection, cells were trypsinized and transferred into T75 flasks. The RBL-2H3 cells overexpressing CRF 2 or CRF 2 shRNA tagged with GFP (CRF 2 overexpressed) or mCherry (CRF 2 shRNA) were sorted on flow cytometry (FACSAria II; Becton Dickinson, Franklin Lakes, NJ [UNC, Chapel Hill, NC]) based on the GFP-or mCherry-positive cells, expanded in culture, and the RBL-2H3 cell aliquots were stored in liquid nitrogen for further study.
CRF 2 small interfering RNA knockdown in RBL-2H3 cells
RBL-2H3 cells grown overnight seeded at a concentration on 5 3 10 5 in a 6-well plate were transfected with CRF 2 small interfering RNA (siRNA; NM-022714; Sigma) or scrambled siRNA (SIC00-1; Sigma) at 150 ng by using Qiagen Hi-Perfect Transfection Reagent, according to the manufacturer's protocol. Six hours after transfection, normal growth medium was added to each well and incubated at 378C with 5% CO 2 for 48 hours. After incubation, transfected cells were primed or not with IgE overnight and stimulated with 1 hour of DNP or A23187 (non-IgE primed), and the b-hex, histamine, and calcium mobilization assay was done, as described above.
Human MC experiments with LAD2 cells LAD2 cells provided by A. Kirshenbaum (National Institutes of Health, Bethesda, Md) were cultured in StemPro-34 (Life Technologies, Carlsbad, Calif) medium supplemented with StemPro-34 Nutrient Supplement (Life Technologies) L-glutamine (2 mmol/L; Life Technologies), penicillin (100 U/ mL)/streptomycin (100 mg/mL), and recombinant human stem cell factor (100 ng/mL; PeproTech, Rocky Hill, NJ). Cell density was kept at less than 0.5 3 10 6 /mL, and half the amount of medium was replaced weekly. Cells were sensitized overnight with 100 ng/mL biotinylated human IgE (US Biological, Salem, Mass). On the following day, cells were washed with Tyrode buffer to remove excess IgE and stimulated with vehicle (0.1% BSA in PBS), streptavidin (100 ng/mL), and 1 to 100 nmol/L human Astressin 2B (kind gift from Jean Rivier, Salk Institute, La Jolla, Calif). b-Hex release was measured after 1 hour of stimulation, as described above.
RT-PCR
Total RNA was extracted from heart tissue and BMMCs by using TRIzol Reagent (Invitrogen), followed by DNase treatment and purification with the PureLink RNA mini kit (Life Technologies). cDNA was synthesized and amplified by using the SuperScript III One-Step RT-PCR System with CRF 1 -specific primers (KSPQ12012 Sigma) and CRF 2 specific primers (KSPQ12012, Sigma). GAPDH forward 5'-TGCACCACCAACTGCTTAG-3' and reverse 5'-GGATGCAGGGATGATGATGTTC-3' was used as normalizing control. For RBL-2H3 cells, total RNA was isolated by using the Qiagen RNeasy kit and transcribed to cDNA by using the Maxima First Strand cDNA Synthesis Kit (Thermo Fisher Scientific). CRF 2 expression was determined by using CRF 2 -specific primers (forward Rat 1_Crhr2: ACTCTACTATGA-GAATGAGCAG and reverse Rat 1_Crhr2: TGACGATGTTGAACA-GAAAC; Sigma-Aldrich).
Intracellular Ca 21 measurements
RBL-2H3 cells and murine BMMCs derived from WT and CRF 2 2/2 mice were used for this study. On the day of the experiment, cells were washed and resuspended in calcium assay buffer. Changes in intracellular calcium levels in response to stimulus were detected by using the Fluo 4 NW Calcium assay kit (Thermo Fisher Scientific), according to the manufacturer's instructions. Briefly, cells were loaded at 378C for 30 minutes with the fluorescent Ca 21 indicator Fluo 4 NW in the presence of probenecid, followed by incubation at room temperature for another 30 minutes. Changes in fluorescence were measured by stimulating the cells by adding different concentrations of DNP/HSA, A23187, or C48/80. Change in fluorescence was measured by using the FDSS/mCELL kinetic plate reader (Hamamatsu, Hamamatsu, Japan) or Fluoroskan Ascent FL microplate reader (Thermo Fisher Scientific) at 480-nm excitation and 540-nm emission. The ratio was calculated based on the average increase in fluorescence divided by the baseline and determined for each time point after the addition of stimulus.
Store-operated Ca 21 entry channel expression BMMC lysates were prepared by resuspending cells in RIPA buffer (Thermo Fisher Scientific) containing protease and phosphatase inhibitors (Thermo Fisher Scientific) at 48C. Lysates were sonicated and centrifuged at 21,000g for 10 minutes. The protein concentration was measured by using the DC Protein Assay Kit (Bio-Rad Laboratories, Hercules, Calif). Cellular proteins were separated by means of SDS-PAGE and transferred to a polyvinylidene difluoride membrane. Membranes were blocked with 5% wt/vol BSA in Tris-buffered saline with 0.1% Tween 20 (TBS-T) for 1 hour at room temperature, washed in TBS-T, and incubated with the rabbit anti-human antibodies anti-stromal interacting molecule 1 (STIM1; #ACC-063; 1:500 dilution; Alomone Labs, Jerusalem, Israel), anti-transient receptor potential canonical 1 (TRPC1; #ACC-010; 1:600 dilution; Alomone Labs), anti-Orai1 (#ACC-060; 1:400 dilution; Alomone Labs), and b-actin (4970, 1:1000; Cell Signaling, Danvers, Mass) diluted in 5% wt/vol BSA in TBS-T overnight at 48C or 2 hours at room temperature and then washed with TBS-T. Subsequently, the membranes were incubated with rabbit polyclonal secondary antibody (7074; 1:2000; Cell Signaling) for 1 hour at room temperature, washed with TBS-T, and incubated in SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific). Bands were visualized with the ChemiDoc MP Imager (Bio-Rad Laboratories), and Image Lab software (version 4.1) was used for densitometric analysis.
Restraint stress model
Female mice were placed in individual, transparent, 50-mL, plastic conical tubes modified with air holes for a 3-hour period. Control mice remained in their original home cages for 3 hours without food and water to avoid the confounding effects of water or food intake during the 3-hour experimental period. After restraint stress, mice were immediately euthanized by means of CO 2 inhalation, and serum and ileal mucosa were collected for measurement of serum histamine and intestinal permeability, respectively. 
BMMC engraftment in
Statistical analysis
In vivo and in vitro studies are presented as means 6 SEs from a representative experiment with 6 to 8 animals per treatment group (unless otherwise specified). Experimental results were repeated in a minimum of 2 independent experiments, whereas some experiments were repeated in greater than 2 independent experiments (noted in the figure legends). Comparisons between multiple experimental groups were performed by using a 1-or 2-way ANOVAwhere appropriate with a Tukey posttest. Comparisons between 2 treatments were analyzed by using an unpaired 2-tailed t test. P values of less than .05 were considered statistically significant. All statistical analyses and calculations were performed with GraphPad Prism 5 software (GraphPad, La Jolla, Calif).
RESULTS
CRF 2 deficiency exacerbates PSA-induced MC degranulation, anaphylaxis, and intestinal permeability
To define the role of CRF 2 in MC-associated disease in vivo, we compared MC responses and associated pathophysiology in an MC-dependent model of IgE-mediated PSA. Compared with WT mice, CRF 2 2/2 mice exhibited greater (by 4.1-fold) serum histamine levels measured at 30 minutes after PSA challenge (5017 6 919 and 1208 6 235 ng/mL in CRF 2 2/2 and WT mice, respectively; P < .001; Fig 1, A) . In agreement with serum histamine levels, CRF 2 2/2 mice exhibited a greater peak reduction in body temperature measured at 30 minutes post-DNP challenge (D 24.558C 6 0.858C and D 26.88C 6 0.548C in WT and CRF 2 2/2 mice, respectively; P 5 .04; Fig 1, B) . Measurement of cardiac blood volume reduction, an index of systemic vasodilation and fluid extravasation induced by PSA, 27, 28 was also greater in CRF 2 2/2 mice at 30 and 120 minutes after DNP challenge compared with that in WT mice (Fig 1, C) , thus indicating a more severe hypovolemic shock response in CRF 2 2/2 mice. Intestinal permeability, measured as FD4 flux rate and reduced TER across ileal mucosa mounted on Ussing chambers, was greater in CRF 2 2/2 mice compared with that in WT mice 120 minutes after PSA (Fig 1, D and E) . Quantification of tissue MCs by using toluidine blue staining of heart, intestinal mesentery, and skin showed that WT and CRF 2 2/2 mice had similar distributions and numbers of tissue MCs (Fig 1, F-H) . Furthermore, circulating basophil numbers were similar between WT and CRF 2 2/2 mice, confirming that increased histamine levels in CRF 2 2/2 mice were not due to increased basophil numbers.
Given that many MC-dependent diseases exhibit a female sex bias and based on our previous studies demonstrating sex differences in MC responses, 25 we also compared the influence of CRF 2 deficiency on PSA-induced serum histamine responses in female and male mice. These studies confirmed our previous research showing that female mice exhibit a greater release of serum histamine compared with male mice. CRF 2 2/2 deficiency exacerbated serum histamine responses in both female and male mice (see Fig E1 in this article's Online Repository at www. jacionline.org). Therefore we conducted subsequent experiments predominantly in female mice. Together, these experiments revealed a significant in vivo role for CRF 2 in IgE-mediated MC degranulation, anaphylaxis, and intestinal permeability.
CRF 2 expressed on MCs is a negative modulator of MC degranulation
CRF receptors are widely expressed in numerous cell types, including MCs, 20, 29, 30 but little is known regarding the localization or functional role of CRF 2 in MC function. By using confocal microscopy, CRF 2 was found to be localized to both the surface and intracellularly in BMMCs and peritoneal (tissue) MCs (Fig 2) . Furthermore, a nuclear staining pattern of CRF 2 was also observed predominantly in BMMCs compared with peritoneal MCs. Flow cytometry confirmed the surface expression of CRF 2 in BMMCs (see Fig E2, G, in this article's Online Repository at www.jacionline.org). CRF 1 showed a different pattern of expression, with a predominant surface localization in peritoneal MCs and BMMCs, and some intracellular staining was observed mostly in BMMCs.
To explore the functional role of MC CRF 2 2/2 , we conducted in vitro degranulation assays with BMMCs derived from WT and CRF 2 2/2 mice. In line with in vivo PSA studies, CRF 2
2/2
BMMCs exhibited exacerbated degranulation responses measured as enhanced b-hex release after IgE-FcεRI crosslinking (Fig 3, A) . Transmission electron microscopy revealed a more activated appearance of CRF 2 2/2 BMMCs after IgE/DNP compared with WT BMMCs, thus supporting the b-hex data (Fig 3, D) .
To determine whether the exacerbated MC degranulation responses observed in CRF 2 2/2 BMMCs were specific to IgEFcεRI-mediated pathways, WT and CRF 2 2/2 BMMCs were also stimulated with non-IgE-dependent MC stimuli, including C48/80, which acts through the GPCR Mrgpb2, 31 and A23187, which acts on downstream store-operated Ca 21 entry (SOCE) mechanisms from intracellular (eg, endoplasmic reticulum [ER]) and extracellular stores. 32 Similar to IgE stimulus, CRF 2 2/2 BMMCs exhibited exacerbated b-hex release in response to both A23187 and C48/80 (Fig 3, B and C) . Because our previous work demonstrated that CRF 1 potentiates stimuliinduced MC degranulation, 22 we investigated whether enhanced degranulation in CRF 2 2/2 BMMCs could be due to a reciprocal upregulation of CRF 1 expression. Quantitative PCR showed that compared with WT BMMCs, CRF 2 expression was downregulated in CRF 2 2/2 BMMCs (by approximately 40%) but CRF 1 expression was not significantly altered (see Fig E3, A and B, in this article's Online Repository at www.jacionline. org). It should be noted that because the loss of CRF 2 activity in CRF 2 2/2 BMMCs (derived from CRF 2 2/2 mice) is a result of a functional deletion of a C-terminal region, CRF 2 is still expressed, as shown in Fig E3, A, although at a lower level than WT BMMCs. There were no significant differences between WT and CRF 2 2/2 BMMCs with regard to the cellular content of b-hex or phenotype determined based on c-kit/FcεRI expression by means of flow cytometric analysis (see Fig E2) , confirming that enhanced degranulation in CRF 2 2/2 BMMCs was not due to an increased intracellular granule mediator content or aberrant MC phenotype.
To further examine the link between CRF 2 expression on MCs and degranulation responses, we transfected CRF 2 plasmid into RBL-2H3 MCs to enhance CRF 2 expression. We confirmed the specificity of CRF 2 overexpression by using quantitative PCR, which revealed upregulation of CRF 2 expression (by 6.4-dold, see Fig E3, C) compared with the empty GFP plasmid while having no significant effect on CRF 1 expression (see Fig E3, D) . CRF 2 -overexpressed RBL-2H3 MCs exhibited suppressed IgE/DNPmediated b-hex release (by 47%) compared with empty plasmid controls (Fig 3, E) . We also knocked down CRF 2 expression in RBL-2H3 MCs with CRF 2 -directed siRNA, which resulted in a 2-fold increase in b-hex release after IgE/DNP stimulation, compared with scrambled siRNA controls (Fig 3, F) . Pharmacologic inhibition of CRF 2 with the selective antagonist Astressin 2B enhanced IgE-FcεRI-induced b-hex release in both rat RBL-2H3 and human LAD2 MCs (Fig 4) , thus confirming the genetic experiments and translational significance to human MCs.
Given our previous work showing that MC CRF 1 potentiates MC degranulation while in the present study CRF 2 suppressing MC degranulation, we hypothesized that MC CRF 1 (Fig 1, D) and TER (FIg 1, E) . F-H, Tissues from WT and CRF 2 2/2 mice were fixed and stained with toluidine blue, and MC counts were performed and presented as MCs per high-power field (hpf). G, Blood basophils were counted in blood smears and expressed as the percentage of basophils per 100 WBCs. Data are means 6 SEMs from a representative experiment with 6 animals per group. Experiments were repeated in 6 (serum histamine levels and body temperature) or 2 (cardiac volume and MC and basophil counts) independent replicates. #,*Symbols differ by P < .05 by using a 1-way ANOVA (Fig 1, A and D) . Different asterisks indicate significance determined by using unpaired 2-tailed t tests (Fig 1, B, C , and E): *P < .05 and **P < .01.
CRF 2 negatively regulates SOCE in MCs
We next explored the mechanism by which CRF 2 caused suppression of stimuli-induced MC degranulation. Because CRF 2 was shown to negatively modulate MC degranulation induced by diverse MC stimuli that use upstream receptor-dependent pathway (IgE-FcεRI and C48/80) or downstream receptorindependent pathway (A23187) mechanisms, we hypothesized that CRF 2 was targeting a common downstream signaling mechanism used by MC degranulation stimuli. SOCE from intracellular (ER and Golgi) and extracellular stores is essential for MC granule exocytosis and degranulation. 33 (Fig 6, A and B) . However, EDTA did not ablate the heightened Ca 21 signaling in CRF 2
2/2
BMMCs compared with WT BMMCs (Fig 6, B and C BMMCs. CRF 2 2/2 BMMCs also exhibited increased expression of SOCE channels, including the ER Ca 21 sensor STIM1 and the plasma membrane channels TRPC1 and Orai1 (Fig 6, D-I) . Together, these data indicate that CRF 2 is a negative and global modulator of stimuli-induced Ca 21 signaling with actions on intracellular release and subsequent extracellular Ca 21 entry.
CRF 2 2/2 mice exhibit increased serum MC histamine and intestinal permeability in response to acute restraint stress
In vitro MC culture experiments revealed that MC CRF 2 exerted suppressive effects on MC degranulation induced by a diverse array of potent MC stimuli. Given these findings, we hypothesized that the global effects of CRF 2 on MC degranulation would extend to non-IgE-dependent in vivo models of MC degranulation. To test this hypothesis, we compared MC degranulation responses through measurement of serum histamine levels in WT and CRF 2 2/2 mice after a 1-hour period of psychological (Fig 2, C) .
J ALLERGY CLIN IMMUNOL VOLUME 143, NUMBER 5 (Fig 3, B) and C48/80 (Fig 3, C) . D, Transmission electron microscopic analysis of WT and CRF 2 2/2 BMMCs stimulated with IgE/DNP. E and F, b-Hex release from RBL-2H3 MCs transfected with CRF 2 -overexpressing plasmid or empty GFP control or CRF 2 siRNA. Data are means 6 SEMs from a representative experiment with 3 (bone marrow donors) per group. Experiments were repeated in 6 (Fig 3, A-C ) or 2 (Fig 3, E and F) independent replicates. Significance between groups was determined by using an unpaired 2-tailed t test: *P < .05, **P < .01, and ****P < .0001.
restraint stress. Compared with WT mice, CRF 2 2/2 mice exhibited higher serum histamine levels after restraint stress (97.7 6 5.9 and 68.2 6 7 ng/mL in CRF 2 2/2 and WT mice, respectively; P < .01; Fig 7, A) . We also assessed colonic permeability measured as FD4 flux rates on Ussing chambers, which showed a significantly increased FD4 flux rate in CRF 2 2/2 mice after restraint stress compared with that seen in WT mice (Fig 7, B) . Together, these data indicate that CRF 2 plays a global role in controlling MC degranulation and associated tissue pathophysiology induced by diverse stressors.
MC CRF 2 is a negative modulator of stress-induced intestinal permeability
The above experiments demonstrated an important role for CRF 2 as a negative modulator of MC-dependent intestinal permeability induced by PSA and restraint stress. Furthermore, in vitro experiments demonstrated the role of MC-specific CRF 2 in the control of stimuli-induced MC degranulation. We next determined the in vivo significance of CRF 2 expressed on MCs using a MC knock-in model. MC-deficient Kit W-sh/W-sh mice were systemically engrafted with BMMCs derived from either WT or CRF 2 2/2 mice. Twelve weeks after engraftment, mice underwent 3 hours of restraint stress, and colonic permeability was measured in Ussing chambers. Compared with Kit W-sh/W-sh mice engrafted with WT BMMCs, CRF 2 2/2 engrafted mice exhibited the greater colonic permeability responses measured as FD4 flux rates (Fig 8,  A) . WT and CRF 2 2/2 mice exhibited similar reductions in colonic TER after restraint stress (Fig 8, B) . Toluidine blue staining and MC counts in intestinal mesenteric tissue confirmed an equal engraftment rate between WT and CRF 2 2/2 BMMCs in MCdeficient Kit W-sh/W-sh mice (Fig 8, C) .
DISCUSSION
Stress is an important risk factor in the clinical onset and severity of important immunologic disorders, including allergy, asthma, and functional and inflammatory gastrointestinal disorders. MCs play a central role in many immunologic diseases and are a critical immune effector cell in the stress response. MCs are rapidly activated within minutes of exposure to diverse stressors, including psychological, chemical, and physical stressors, resulting in release of preformed granule mediators (eg, histamine, proteases, and TNF) through degranulation. Released MC mediators evoke profound physiologic effects in local and systemic tissues, such as increased epithelial and endothelial permeability, neuronal activation, and circulatory changes. Although stress-induced MC activation likely represents an early defense or alarm mechanism to mobilize resources necessary for the subject to respond appropriately to the stressor, excessive or prolonged MC activation is harmful, leading to immune dysregulation and tissue damage and exacerbation of disease. Although the major MC stimuli have been identified, how environmental factors, such as stress, play a role in exacerbating or limiting MC activation remains poorly understood. Here we demonstrated a novel function for CRF 2 expressed on MCs as a negative modulator of stimuli-induced MC degranulation and MC-dependent pathophysiology associated with anaphylaxis and acute psychological stress.
Previous studies conducted in vitro with human and rodent MCs demonstrated that MCs express both CRF 1 and CRF 2 receptors 22, 23 and that CRF receptor ligands can induce canonical GPCR pathways, including cyclic AMP and phosphorylated extracellular signal-regulated kinase signaling. 19, 22, 34 However, the precise role of the MC CRF system modulating MC function and MC-mediated disease pathogenesis has remained elusive. Recently, we demonstrated that CRF 1 receptor signaling in the MC is a potentiator of stimuli-induced MC degranulation and intestinal pathophysiology induced by PSA and psychological restraint stress. 35 In the present study our data revealed that, in contrast to CRF 1 , CRF 2 exerts inhibitory actions on MC degranulation because loss of CRF 2 activity in MCs through genetic or pharmacologic approaches resulted in enhanced stimuli-induced MC degranulation and exacerbated responses to PSA and acute restraint stress. Selective inhibition of CRF 1 was shown to reduce PSA-induced MC responses in CRF 2 2/2 mice to levels seen in WT mice, overall indicating that MC CRF 1 and CRF 2 act in concert to upregulate and downregulate, respectively, the tone of MC degranulation and resultant MC-dependent pathophysiology. Therefore it is plausible that a disruption of MC CRF 1 and CRF 2 homeostasis could shift the balance between hypoactivated and hyperactivated MC states and ultimately disease activity. -replete (Fig 6, A) or Ca 21 -free (1 mmol/L EDTA; Fig 6, B) conditions. C, Mean peak change in fluorescence after IgE/DNP stimulus presented as D peak fluorescence. D-I, Representative Western blots and densitometric analysis for STIM1 (Fig 6, D and G) , TRPC1 (Fig 6, E and H) , and Orai (Fig 6,  F and I ) in WT and CRF 2 2/2 BMMCs. *Significance between groups was determined by using an unpaired 2-tailed t test (Fig 6, C and G-I). *P < .05 and **P < .01.
The broad inhibitory actions of CRF 2 on multiple MC degranulation stimuli and in vivo models led us to hypothesize that CRF 2 was targeting a common downstream mechanism in MC degranulation. Results from the present study demonstrated that MC CRF 2 expression was negatively associated with Ca 21 mobilization induced by a diverse array of MC stimuli, including IgE antigen, c48/80, and the muscarinic receptor 3 agonist carbachol. (Fig 8, A) and TER (Fig 8, B Confocal microscopy revealed that CRF 2 was localized on the surfaces of MCs and intracellularly. Furthermore, intranuclear expression of CRF 2 was also observed. In comparison, CRF 1 was localized predominantly to the cell surfaces of MCs with no apparent nuclear staining patterns. Together, these finding demonstrate differential cellular localization patterns between CRF 1 and CRF 2 , but the relationship between cellular localization and divergent functions in MC activation requires further investigation. It has become increasingly clear that a number of GPCRs target to the nuclear membrane 38 and can regulate DNA synthesis, 39 transcription and gene expression, 40 and histone modification. 41 To our knowledge, this represents the first evidence for differential localization of CRF receptor subtypes in MCs, and further investigations will likely provide insight into the divergent roles that CRF 1 and CRF 2 play in MC function and provide valuable insight into approaches for potential therapeutic modulation.
Precisely how the CRF receptor system is regulated to maintain MC homeostasis with regard to degranulation remains to be fully defined. We and others have shown that MCs release CRF 1 /CRF 2 ligands CRF and urocortin under basal and stimulated conditions 21, 22 and that CRF 1 and CRF 2 receptors modulate stimuliinduced MC degranulation in vitro in the absence of exogenous ligands. Together, these findings demonstrate that MCs possess a functional CRF system and implicates an autocrine regulation mechanism. Such a system could explain the ability of the MC CRF system to modulate rapid cellular signaling events in the MCs, such as Ca 21 mobilization degranulation events. In view of the CRF system as a homeostatic regulator of the stress response, activation of CRF 1 in MCs could provide immunologic protection by enhancing MC degranulation and subsequent physiologic and immunologic responses, especially during times of acute stressful challenges. On the other hand, CRF 2 activation can provide a critical homeostatic mechanism by limiting the extent of degranulation and downstream pathophysiology. Dysfunction or imbalance of this system could lead to aberrant MC function and heightened disease states. It has been shown in cultured MCs that CRF 1 and CRF 2 expression levels can be influenced by psychological stress exogenous CRF receptor ligand, substance P, and LPS. 18, 20 There is also substantial evidence in human subjects and animal models that CRF 1 and CRF 2 expression is altered under pathologic conditions, such as urticaria, 42 colitis, 15, 43 and chronic and early-life stress. 44, 45 The contribution of altered CRF receptor expression versus function in MC-associated disease pathogenesis remains to be fully elucidated.
In summary, the present study highlights a novel role for CRF 2 receptors expressed on MCs as negative modulators of MC degranulation in the acute response to immunologic and psychological stress. Given the critical role of MCs as immune sentinels that rapidly respond to diverse stressful stimuli, the MC CRF 2 system might represent a critical control step to limit MC degranulation and disease pathophysiology. Further understanding of the precise mechanism by which CRF 2 controls MC degranulation and associated disease pathophysiology could unveil new therapeutic targets for immune diseases linked to stress and MC hyperactivity, such as allergic inflammation and IBS.
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